Click below to read this story
The dividend giant boosted earnings, even as sales growth slowed last year.
Norwest Venture Partners has sold PCA Skin, a provider of skin care products, to Colgate-Palmolive Company. No financial terms were disclosed. Financo and Houlihan Lokey advised PCA SKIN on the deal.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Colgate-Palmolive is a high-quality business with steady dividend growth, but investors may want to hold off on buying the currently over-valued stock. The post Colgate-Palmolive a...
* GETS ORDER FROM COLGATE-PALMOLIVE IN COOPERATION WITH SOLAR ++
Colgate-Palmolive Company (NYSE: CL) isn't necessarily the most exciting name for investors to talk about, but heading into 2018 the case can be made to be buyers of the stock. Latest Ratings for CL DateFirmActionFromTo Dec...
Bank of America fell 2.1 percent and Citigroup fell 0.6 percent Wednesday as interest rates continued to retreat from their recent highs, which reduces the profits banks make from lending. Colgate-Palmolive gained 3.1 percent and Church& Dwight...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Colgate Palmolive Company (NYSE:CL) is a constituent of the 14 company Household Products GICS industry group, which is a segment of the 174 company GICS Consumer Staples sector. CL's...
Colgate-Palmolive’s (CL) 3Q17 sales of ~$4.0 billion came in marginally ahead of the analyst estimate of ~$3.9 billion and increased 3.0% year-over-year.
Colgate-Palmolive (CL) reported its 3Q17 earnings on October 27. CL’s adjusted earnings per share of $0.73 were in line with estimates and remained flat on a year-over-year basis.
* Colgate-Palmolive Co files for potential debt shelf offering; size not disclosed - SEC filing Source text (http://bit.ly/2yZlsyt) Further company coverage:
Colgate-Palmolive Co. said Friday it had net income of $607 million, or 68 cents a share, in the third quarter, down from $702 million, or 78 cents a share, in the year-earlier period. Adjusted per-share earnings came to 73 cents, matching the...
Colgate-Palmolive (CL) has disappointed investors with its tepid top-line performance over the past several quarters. It has missed analysts’ sales estimates for the past five quarters.
Colgate-Palmolive (CL) is set to announce its 3Q17 earnings on Friday, October 27, 2017. Wall Street expects its adjusted EPS (earnings per share) to remain flat at $0.73.
Colgate-Palmolive (CL) stock has risen 15.8% on a YTD (year-to-date) basis as of October 16, 2017, and has outperformed most of its peers in terms of stock gains.
On October 11, 2017, SunTrust Robinson Humphrey upgraded Colgate-Palmolive (CL) stock to a “buy” from “hold” and increased the target price.